Galactose-Induced Retinal Microangiopathy in Rats
|
|
- Rose Black
- 6 years ago
- Views:
Transcription
1 Galactose-Induced Retinal Microangiopathy in Rats Timothy S. Kern and Ronald L. Engerman Purpose. The suitability of the galactose-fed rat as a model of diabetic retinopathy was examined in nondiabetic rats fed diets enriched with either 30% or 50% galactose for up to 2 years. Methods. Retinal capillaries were examined by light and electron microscopy, and the prevalence or severity of diabetic-like lesions was quantitated. Results. Histologic evaluation of trypsin digests of retina revealed significantly greater than normal frequencies of pericyte ghosts and acellular capillaries at both 15 and 23 months receiving a 50% galactose diet. Similar lesions were observed in rats receiving a 30% galactose diet for 23 months. Capillary basement membrane thickening, dilated hypercellular capillaries (or intra-retinal microvascular abnormalities), and foci of vascular cells appeared in rats fed 50% galactose, but saccular microaneurysms characteristic of retinopathy in diabetic patients, diabetic dogs, and experimentally galactosemic dogs were not observed. Administration of the aldose reductase inhibitor, Sorbinil, to rats fed 50% galactose resulted in a significant inhibition of cataract and of galactitol accumulation in nerve and blood (by more that 90%) and retina (by 62%), but did not inhibit development of the retinal microvascular lesions. Conclusions. Two years of galactosemia in rats seems to reproduce only a portion of the lesions characteristic of diabetic retinopathy in patients or dogs. Nevertheless, lesions characteristic of at least the early stages of retinopathy clearly do develop in this galactosemic rat model, and are not restrained by inhibition of retinal polyol accumulation by 62%. Invest Ophthalmol Vis Sci. 1995;36: Consumption of a galactose-rich diet by nondiabetic animals affords a means to examine the role of "hyperglycemia" in the etiology of diabetic complications, because it causes elevation of blood aldohexose concentration (galactose) without causing many other metabolic abnormalities that are characteristic of diabetes (such as alterations in concentrations of insulin, glucose, fatty acids, and amino acids). 1 Nondiabetic dogs fed a 30% galactose diet for 3 to 5 years develop a retinopathy that is morphologically indistinguishable from that seen in diabetic patients and diabetic dogs, 1 " 3 including saccular microaneurysms, pericyte ghosts, acellular (nonperfused) capillaries, and intraretinal microvascular abnormalities (IRMA). Thus, studies of experimentally galactosemic dogs indicate From the Dejmrtmenl of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin. Supported in partfrypublic Health Service grant EYQQ300 from the National Eye institute. Submitted for publication March 7, 1994; revised July 14, 1994; accepted September, Proprietary interest category: N. lieprint rei/uests: Timothy S. Kern, Department of Ophthalmology and Visual Sciences, University of Wisconsin, 1300 University Avenue, Madison, WI that hyperglycemia itself is capable of initiating the development of diabetic retinopathy. Consistent with the findings in dogs, rats fed galactose have been reported to develop retinal microvascular disease. 4 ' 5 This galactose-induced retinopathy seems to develop faster in rats than in dogs, and may offer an additional animal model to investigate the role of hyperglycemia in the pathogenesis of diabetic retinopathy. Excessive activity of aldose reductase is one sequela of hyperglycemia that is common to diabetes and galactosemia, and has been postulated to have a role in the development of diabetic complications. The role of the polyol pathway in the development of diabetic retinopathy, however, is controversial. 4 ' 6 " 9 This controversy remains because several critical elements of the experiments (such as ensuring that hyperglycemia was comparably severe in control and inhibitor-treated groups, and documenting the extent to which polyol production and accumulation were inhibited) were neglected in some of the studies. In the current study, we fed rats galactose-rich diets for up to 26 months to evaluate their suitability 490 Investigative Ophthalmology & Visual Sci( Copyright Association for Research in 1 e, February 1995, Vol. 36, No. 2 on and Ophthalmology
2 Retinopathy in Galactose-fed Rats 491 as a model of diabetic retinopathy, and to quantitate the effects of aldose reductase inhibition on the development of such microvascular pathology, paying careful attention to documenting the comparability of glycemia between experimental groups and the biologic efficacy of the aldose reductase inhibitor therapy. METHODS Animals Male Sprague-Dawley rats (200 g each) were randomly assigned to be made galactosemic or to remain as normal control subjects. Experimental galactosemia was produced by offering a diet of rat chow (Purina [Richmond, IN] 5001) enriched with 30% galactose or 50% galactose. The final concentration of protein in the galactose-enriched diets was 17% or 12%, respectively, and the normal control rats received a diet containing 18% protein (Purina 5055). All animals were caged individually, had free access to food and water, and were maintained on a 14 hours on-10 hours off light cycle with cage level light intensity at <15 foot candles. Treatment of animals conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Long-term Hyperglycemia Nonenzymatically glycated hemoglobin (GHb; an estimate of the average level of hyperglycemia during the preceding 2 to 3 months) was measured by affinity chromatography (Glyc-Affin; Pierce, Rockford, IL). The expected elevation of nonenzymatically glycated hemoglobin concentration was not detected in the galactose-fed rats using an alternate method (ion exchange chromatographic method; HbA,), so its use was discontinued. Glycated hemoglobin, hematocrit, and blood glucose concentration were measured 2 to 3 times per year in each animal. Rats were placed in metabolism cages 5 to 7 times throughout the course of the experiment, and on each occasion, 24-hour urine volume and specific gravity were measured on each of two consecutive days. Contamination of urine by galactose-containing food prevented meaningful measurement of galactose excretion. Body weight and food consumption were measured twice per week, and average daily food intake was calculated. Light and Electron Microscopy Animals were killed after an overnight fast at durations of study of up to 26 months. The left eye was placed into formalin for preparation of trypsin-digested retinas, 10 the superior portion of the right eye was fixed in glutaraldehyde for electron microscopy using previously described methods," and the inferior portion was frozen for chemical analysis. The trypsinized retinal vessels were first stained with Oil Red O for sudanophilia, and later restained with periodic acid-schiff and hematoxylin for histologic evaluation. Retinal cells and lesions and basement membrane thickness were quantitated in a masked fashion. Sudanophilia was graded semiquantitatively (0 = none; 3 = much). Endothelial cell and pericyte counts were determined in the mid-retina on approximately 1300 capillary cells per retina, and the number of acellular capillaries was counted in multiple mid-retinal fields (one field adjacent to each of the 5 to 7 retinal arterioles radiating out from the optic disc) and expressed per square millimeter of retinal area examined. No more than 10 acellular capillaries were counted in any one field, so that focal areas of acellularity would not unduly bias the results. The maximum number of acellular capillaries by this method thus was 55 per mm 2. Pericyte "ghosts," indicating where pericytes had been lost, were counted only on capillaries that possessed one or more endothelial cells. Capillary basement membrane width was determined in the superior portion of the retina (mid-retina of the right eye) for representative animals using the method of Siperstein. 12 Fifteen capillaries (3 from each of 5 blocks) of the outer plexiform or inner nuclear layer were measured per animal. Only patent capillaries cut in cross section with a diameter of approximately 3.3 /xm or less were photographed and printed at a final magnification of about X. Coded photographs from animals were intermixed before measurement to ensure unbiased evaluation of the basement membrane width. Identical conclusions were reached using the minimum thickness method 13 (not shown) on the same micrographs. Aldose Reductase Inhibition Rats assigned to the 50% galactose group were further randomly subdivided into untreated and Sorbiniltreated (0.04% w/w in the diet) groups. This dose of Sorbinil (Pfizer, Groton, CT) was selected because of its reported beneficial effects on galactose-induced retinal disease in rats. 14 " 17 To estimate the extent of aldose reductase inhibition during the experiment, galactitol was determined two to four times in blood (100 to 500 y\ whole blood) by gas chromatography/ mass spectroscopy. 18 ' 19 Galactitol was determined also in retina and sciatic nerve, and myoinositol quantitated in retina, of representative animals at autopsy. Uniformly deuterated galactitol and myoinositol (donated by Drs. J. Williamson and W. Sherman, Washington University) were added to each sample as internal standards. Blood and tissue was always collected from rats after an overnight fast, so that no Sorbinil had been ingested for the preceding 12 to 14 hours. Polyol concentrations reported for Sorbinil-treated animals thus are believed to represent the minimum degree
3 492 Investigative Ophthalmology & Visual Science, February 1995, Vol. 36, No. 2 TABLE l. Comparison of Galactosemia Severity During the Duration of Study* GHb (%) Urine Excretion (ml/day) Plasma Glucose (mg/dl) Body Weight (g) Normal () 30% Galactose (11) 50% Galactose (13) 50% Galactose % Sorbinil () 3.2 ± ± ± ± ± 2 35 ± 7 80 ± ± ± ± ± ± ± ± ± ± 38 * Data from animals studied 20 months or longer. of inhibition that occurred throughout the day. Daily consumption of food and Sorbinil are reported herein for three representative periods (months 3, 13 and 19). Lens clarity was assessed after mydriasis at 20 months of galactosemia, and graded semiquantitatively (0 = no lens changes; 4 = dense cataract). Retinopathy was evaluated as described earlier using coded specimens. Experimental groups were compared statistically using analysis of variance followed by Tukey-Kramer tests. The nonparametric Kruskal Wallis test followed by Mann-Whitney U tests yielded similar results. Results are expressed as mean ± SD. RESULTS Glycated hemoglobin and daily urine excretion were consistently elevated throughout the experiment in all galactosemic groups, and galactosemia was most severe in animals consuming the 50% galactose diet (Table 1). The elevated glycated hemoglobin in galactose-fed rats was not due to an increase in blood glucose concentration, because the plasma glucose concentration remained normal in all galactosemic rats throughout the study. Galactose-fed rats gained weight at less than the normal rate, the defect being most severe in rats receiving the higher concentration of galactose. Daily food consumption (per kg body weight) tended to diminish in all groups with increasing age, but was about 25% and 85% greater than normal in animals fed the 30% and 50% galactose diets, respectively. Galactose-induced Retinal Lesions Retinal vascular abnormalities were found at 15 months in the rats fed the 50% galactose diet (Table 2), including a significantly greater than normal incidence of pericyte ghosts (indicating sites of pericyte loss; P < 0.001) and a trend toward increased frequency of acellular capillaries. Individual capillaries and small groups of capillaries became devoid of endothelial and pericyte nuclei, and therefore seemed acellular. Many acellular capillaries, as well as occasional capillaries containing seemingly viable pericytes, exhibited sudanophilic deposits in their vessel wall and/or lumen. The incidence of these and other lesions tended to increase with longer durations of galactosemia. The ratio of capillary endothelial cells to pericytes tended to become slighdy higher than normal after 15 months of galactosemia, but this ratio is unreliable because of difficulties in differentiating all capillary cells in rats. Similar lesions were observed in animals receiving the 30% galactose diet. Acellular (presumably nonperfused) capillaries and sudanophilic capillaries became more numerous with increasing duration of galactosemia. In 4 of 10 rats fed 50% galactose (and no drug) for longer than 22 months, the acellular capillaries were so numerous that much of the microvasculature of the posterior and mid-retina was obliterated. Animals with extensive capillary loss generally possessed some dilated, hypercellular vessels or IRMAs consistent with possible neovascularization (Fig. 1). These abnormal vessels were not distributed uniformly across the posterior pole, but were found in patches with seemingly normal vessels nearby. Saccular capillary microaneurysms such as are characteristic of diabetic humans were not observed, although some vaguely similar focal accumulations of vascular cells were seen, usually at intersections of capillaries (Fig. 2). The significance of these focal accumulations is not clear. Retinal capillary basement membrane thickened as a result of the experimental galactosemia, and was significantly greater than normal at both durations of 50% galactosemia examined (P > 0.01). No retinal folds were seen. Mortality No animals died until the second year of study, and then 10 of 32 normal rats, 12 of 31 rats fed 50% galactose, and 3 of 14 fed 30% galactose died spontaneously. The cause of death was not always apparent, but intestinal obstruction apparently secondary to the diet was found at autopsy in four rats fed the 50% galactose diet but in none of the animals receiving 30% galactose diet or the normal diet. Effect of Aldose Reductase Inhibition Rats in the Sorbinil-treated or untreated groups receiving 50% galactose were compared at a mean duration of 23 months (range, 20 to 26 months; Table 2). The
4 Retinopathy in Galactose-fed Rats 493 TABLE 2. Retinal Microvascular Abnormalities in Galactose-fed Rats (mean ± SD) Duration (months) Normal 30% Galactose 50% Galactose ±1 ± % Galactose. + Sorbinil 23 ± 2 23 ± 2 (n) Acellular Capillaries (per mm2) ±3 ± * ±6 ± 12* ± 14*f Pericyte Ghosts (/1000 cells) ± 0.4 ± 0.2 ± 7.9* ± 1.7* ± 6.9* * SudanophUia (grades 1-3) ± ± 0.7* + 0.3* ± 1.0* ± 0.5*f Basement Membrane Thickness (nm) _ 155 ± 22 (lit) 259 ± 42* (5) 201 ± ± 146* (8) 293 ± 50* (8) * P < O.Oi compared to normal. f P < 0.01 compared to age-matched 50% galactose group. X Values in parentheses represent n. Sorbinil-treated group was not significantly different from the untreated galactosemic group with respect to the severity of galactosemia as estimated by glycated hemoglobin and 24-hour urine excretion. Body weight in Sorbinil-treated galactosemic rats was slightly but significantly less than that in untreated galactosemic animals (P < 0.05). Consumption of food (arid thus galactose) relative to body weight decreased with increasing age in the two 50% galactose groups, but remained greater than normal throughout the experiment, and did not differ between.the two 50% galactose groups at any time. Average daily food intake in the Sorbinil-treated and untreated 50% galactosemic groups, respectively was: during month 3, 100 g/kg body weight/day ± 7 and 97 ± 9; during month 12, 72 ± 7 and 74 ± 7; and during month 19, 71 ± 4 and 69 ± 6. Sorbinil intake in the Sorbiniltreated animals during months 3, 12, and 19, respectively was 39 ± 4 mg/kg body weight/day, 29 ± 2, and 28 ± 3. Dense cataract developed within 2 months in the untreated 50% galactose group. Cataractogenesis was markedly inhibited in Sorbinil-treated animals, and consisted of no more than slight vacuolization or haziness of the lens at 20 months of galactosemia (semiquantitative scores of 0 ± 0, 4 ± 0, and 1.4 ± 0.5, respectively for normal [n = 15], untreated galactosemic [n = 13], and Sorbinil-treated galactosemic [n = ] groups). Galactitol concentration in blood and sciatic nerve in the untreated galactosemia group was, respectively, 123-fold and 43-fold greater than normal, and both of these very large increases in tissue galactitol were inhibited more than 90% by Sorbinil treatment (Table 3). Galactitol accumulation in retinas of galactosemic rats rose to 15-fold that of normal rats. Sorbinil treatment significantly inhibited 62% of this increase (P < 0.001), although this level of inhibition did not prevent the accumulation of retinal galactitol (P< compared to normal). Free myoinositol in the retina was not affected by long-term galactosemia (54 ± 25 nmol/g protein versus 50 ± 18 in normal and galactosemic groups, respectively), and values in FIGURE1. Posterior/mid-region.of trypsin-digested retinas from (left) experimentally galactosemic rat (24 months), and (right) age-matched normal rat. Dilated, hypercellular vessels are visible and numerous degenerate, acellular capillaries lacking nuclei are widespread in the galactosemic. The optic nerve head is out of the micrograph to the left, (periodic acidschiff and hematoxylin; original magnification X100).
5 494 Investigative Ophthalmology & Visual Science, February 1995, Vol. 36, No. 2 FIGURE 2. Foci of vascular cells observed in a galactosemic rat (23 months of galactosemia). These lesions do not resemble saccular microaneurysms characteristic of diabetic retinopathy in patients. Acellular capillaries {arrowheads) and a pericyte ghost {arrow) are visible, (periodic acid-schiff and hematoxylin; original magnification X375). FIGURE 3. Intra-retinal microvascular abnormalities adjacent to a retinal vein of a galactosemic rat treated with Sorbinil for 24 months. Note the extensive loss of viable capillaries in this area, as indicated by the absence of nuclei in most capillaries, (periodic acid-schiff and hematoxylin; original magnification X150). Sorbinil-treated animals (37 ± 22), although not significantly different, tended to be lower than those in normal or galactosemic animals. Retinal lesions in Sorbinil-treated galactosemic animals were equally or more severe than those in the untreated galactosemic rats (Table 2), and retinal capillary basement membrane thickening was not inhibited in our Sorbinil-treated rats. IRMAs were observed in animals receiving the aldose reductase inhibitor (Fig. 3), and all capillaries in large areas of the posterior and mid-retina were acellular in 9 of the 11 Sorbinil-treated rats receiving 50% galactose for more than 21 months. tosemic rat model Evidence that experimental galactosemia was capable of producing a diabetes-like retinopathy first was reported by us in 1982 in dogs,2 and galactose-induced thickening of retinal capillary basement membranes in rats was reported the next year.14'15 Robison et al. reported that three rats fed a diet enriched with 50% galactose for 28 months developed a retinopathy that they regarded as diabetic-like in appearance.4'24 The current study confirms that prolonged consumption of a 50% galactose diet by nondiabetic rats leads to the development of a retinal microangiopathy that resembles the early stages of diabetic retinopathy in important respects. The retinal lesions in our animals include pericyte loss, acellular capillaries, thickened capillary basement membrane and IRMAs. The IRMAs consist of hypercellular foci of vascular cells, usually adjacent to a large area of acellular (presumably nonperfused) capillaries. Retinal folds, observed by others in rats at 20 months of galactose-feeding, and retinal hemorrhages were not seen by us either grossly or in retinal cross sections. Saccular capillary microaneurysms were absent in our DISCUSSION Experimental galactosemia has proved to be a valuable tool in the study of the pathogenesis of diabetic complications because it reproduces some of the anatomic complications of diabetes in the absence of many of the metabolic abnormalities characteristic of diabetes.' The development of cataract and nerve abnormalities have been extensively probed using the galac- 3. Tissue Galactitol Concentration in Rats Fed 50% Galactose (mean ± SD) TABLE Normal 50% Galactose 50% Galactose + Sorbinil Erythrocytes (nmol/mg Hb) Sciatic Nerve (nmol/mg protein) Retina (nmol/mg protein) 0.1 ± 0.2 (17) 6.2 ± 1.5 (17) 0.6 ± 0.3 () 5 ± 1 (7) 214 ± 129 (6) 26 ± 5 (6) 2.2 ± 2.1 (9) 32.4 ± 12.5 (9) 13.6 ± 5.7 (11) P < for each comparison between groups in a column. Values in parentheses represent n.
6 Retinopathy in Galactose-fed Rats 495 galactose-fed rats, although focal accumulations of vascular cells that might be mistaken for aneurysms were seen. Thus, 2 years of galactosemia in rats seems to reproduce only a portion of the spectrum of lesions characteristic of diabetic retinopathy in patients or dogs, but experimentally galactosemic rats are likely to be a useful model of at least the early stages of diabetic retinopathy. Whether or not unequivocal saccular microaneurysms and more advanced lesions would eventually develop reproducibly in rats as they do in patients and dogs is not clear. The acellular capillaries and pericyte ghosts that develop reproducibly in galactose-fed rats are among the earliest structural abnormalities demonstrable in diabetic retinopathy or galactose-induced retinopathy. Pericyte loss has long been recognized to occur in the early stages of retinopathy, but the significance of early development of individual or small groups of acellular, nonperfused capillaries has been appreciated less. A progressive increase in the number of nonperfused capillaries can lead to retinal ischemia, and is likely to be an important factor leading to neovascularization and proliferative retinopathy in diabetes. The cause of retinal capillary occlusion and acellularity is unknown. Similar to the retinal lesions caused by 50% galactose, retinal microvascular disease also developed in rats fed 30% galactose. Daily, these animals ingested less than half the quantity of galactose consumed by rats fed the 50% galactose diet. A diet of 30% galactose is less costly, but most importantiy, seems to result in healthier rats than those receiving the 50% galactose diet. The 30% galactose diet was associated with less evidence of galactose toxicity such as impaired growth and intestinal obstruction than seen with the 50% galactose diet. In our laboratory, retinopathy induced by 50% galactose in rats was not inhibited by administration of 0.04% Sorbinil. Sorbinil-treated galactosemic rats were found to have no fewer pericyte ghosts, acellular capillaries, shunt vessels, or hypercellular foci of vascular cells than their untreated galactosemic counterparts, and thickening of capillary basement membrane was not inhibited in the Sorbinil-treated animals. Our findings are contrary to those of previous studies of galactosemic rats in which Sorbinil added to the diet at the same or lower concentration was reported to inhibit thickening of retinal capillary basement membranes. 14 " Moreover, retinopathy has reportedly been prevented in 3 galactosemic rats fed an aldose reductase inhibitor, tblrestat, for 28 months. 4 ' 24 The reason for the disparate results about the ability of aldose reductase inhibitors to prevent retinal pathology is not clear. The dose of Sorbinil given herein is- equal to or higher than that reported by others to inhibit galactose-induced thickening of retinal capillary basement membrane or alterations in retinal blood flow and permeability in rats. 14 " 17 Administration of Sorbinil to our animals inhibited galactitol accumulation in erythrocytes and extraocular tissues of our galactosemic rats by more than 90%, and cataract was markedly inhibited. However, polyol pathway inhibition in the retina seemed less than in blood, sciatic nerve, and lens, and the concentration of galactitol in retinas of Sorbinil-treated rats remained greater than normal. The polyol concentration in retina and other tissues has not been measured by other workers studying the relationship of the polyol pathway to retinopathy, and the lack of such data from their reports prevents meaningful comparison with our observations. Inhibition of the polyol pathway to the extent achieved in the rats in pur study clearly did not inhibit the development of galactose-induced retinopathy. Studies in diabetic dogs and galactosemic dogs (where polyol accumulation \n the retina was inhibited by 100% and 96%, respectively) and in diabetic humans have revealed no effect 7 " 9 or a possibly transient effect 6 of available aldose. reductase inhibitors on the development of retinopathy. Key Words retinopathy, galactosemia, rat, polyol pathway, aldose reductase inhibitor Acknowledgments Sorbinil was provided by Pfizer, Inc. The authors thank M. Garment, M. Larson, and J. Heen, for their skillful technical assistance. References 1. Engerman RL, Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 1984; 33: Engerman RL, Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 1982; 31(Suppl):26A. 3. Engerman RL, Kern TS. Hyperglycemia as a cause of diabetic retinopathy. Metabolism. 1986;35(Suppl 1): Robison WG Jr, Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci. 1989;30: Robison WG Jr, Tillis TN, Laver N, Kinoshita JH. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. Exp Eye Res. 1990;50: Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 1990;108: Engerman RL, Kern TS. Aldose reductase inhibition
7 496 Investigative Ophthalmology & Visual Science, February 1995, Vol. 36, No. 2 fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes. 1993;42: Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch Ophthalmol. 1990; 108: Arauz-Pacheo C, Ramiriz LC, Pruneda L, Sanborn GE, RosenstockJ, Raskin P. The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy. J Diabet Complications. 1992;6; Kuwabara T, Cogan DG. Retinal vascular patterns. VI. Mural cells of retinal capillaries. Arch Ophthalmol. 1963; 69: Engerman RL, Kern TS, Garment MB. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition. J Diabet Complications. 1993;7: Siperstein M, Unger R, Madison L. Studies of muscle capillary basement membrane in normal subjects, diabetic, and prediabetic patients. J Clin Invest. 1968; 47: Williamson JR, Vogler NJ, Kilo C. Estimation of vascular basement membrane thickness. Diabetes. 1969; 18: Frank RN, Keirn RJ, Kennedy A, Frank KW. Galactoseinduced retinal capillary basement membrane thickening: Prevention by Sorbinil. Invest Ophthalmol Vis Sci. 1983;24: Robison WGJr, Kador PF, KinoshitaJH. Retinal capillaries: Basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science. 1983;221: Vinores SA, Campochiaro PA. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition. Exp Eye Res. 1989; 49: Tilton RG, Chang K, Weigel C, et al: Increased ocular blood flow and l25 I-albumin permeation in galactosefed rats: Inhibition with sorbinil. Invest Ophthalmol Vis. Sti. 1988; 29: Eades DM, Williamson JR, Sherman WR. Rapid analysis of sorbitol, galactitol, mannitol and myoinositol from biological sources. / Chromatogr. 1989;490: Kern TS, Engerman RL. Retinal polyol and myo-inositol in galactosemic dogs given an aldose reductase inhibitor. Invest Ophthalmol Vis Sti. 1991; 32: KinoshitaJH. Cataracts in galactosemia. Invest Ophthalmol. 1965;4: Powell HC, Myers RR. Schwann cell changes and demyelination in chronic galactose neuropathy. Muscle Nerve. 1983; 6: Mizisin AP, Powell HC, Myers RR. Edema and increased endoneurial sodium in galactose neuropathy: Reversal with an aldose reductase inhibitor. J Neurol Sri. 1986; 74: Willars GB, Lambourne JE, Tomlinson DR. Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes? Diabetes. 1987; 36: Robison WG Jr, Nagata M, Tillis TN, Laver N, KinoshitaJH. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Invest Ophthalmol Vis Sti. 1989;30:
The role of hyperglycemia in the pathogenesis of. Kidney Morphology in Experimental Hyperglycemia
Kidney Morphology in Experimental Hyperglycemia TIMOTHY S. KERN AND RONALD L. ENGERMAN SUMMARY To evaluate the role of hyperglycemia in the pathogenesis of diabetic nephropathy, the kidneys from dogs experimentally
More informationThe Natural History of Diabetic Retinopathy and How Primary Care Makes A Difference
The Natural History of Diabetic Retinopathy and How Primary Care Makes A Difference We will discuss - How exactly does blood sugar control affect retinopathy? - What are other factors that we measure in
More informationProgression of sugar cataract in the dog
See discussions, stats, and author profiles for this publication at: http://www.researchgate.net/publication/21253355 Progression of sugar cataract in the dog ARTICLE in INVESTIGATIVE OPHTHALMOLOGY &
More informationEyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion
EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion George Bresnick MD MPA Jorge Cuadros OD PhD Anatomy of the eye: 3 Normal Retina
More informationPART 1: GENERAL RETINAL ANATOMY
PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is
More informationEpidemiology and Pathophysiology of Diabetic Retinopathy
Epidemiology and Pathophysiology of Diabetic Retinopathy Vincent Reppucci, MD Director, Retina Service Mt. Sinai St. Luke s-roosevelt Hospital Attending Physician, Retina Service New York Eye and Ear Infirmary
More informationZhong-Yang Lu*, Imran Ahmed Bhutto and Tsugio Amemiya
Retinal Changes in Otsuka Long-Evans Tokushima Fatty Rats (Spontaneously Diabetic Rat) Possibility of a New Experimental Model for Diabetic Retinopathy Zhong-Yang Lu*, Imran Ahmed Bhutto and Tsugio Amemiya
More informationReduction of Basement Membrane Thickening in Diabetic Cat Retina by Sulindac
Investigative Ophthalmology & Visual Science, Vol. 1, No., March 1990 Copyright Association for Research in Vision and Ophthalmology Reduction of Basement Membrane Thickening in Diabetic Cat Retina by
More informationInflammatory basis of diabetic retinopathy. Tim Kern, PhD Case Western Reserve University and Stokes VA Hospital, Cleveland, OH
Inflammatory basis of diabetic retinopathy Tim Kern, PhD Case Western Reserve University and Stokes VA Hospital, Cleveland, OH Diabetic retinopathy currently is diagnosed based on vascular abnormalities
More informationRetinal complications of diabetes mellitus are the principle
Correction of Early Subnormal Superior Hemiretinal PO 2 Predicts Therapeutic Efficacy in Experimental Diabetic Retinopathy Bruce A. Berkowitz, 1,2 Yasuki Ito, 1,2 Timothy S. Kern, 3 Christopher McDonald,
More informationLongitudinal Validation Study: Streptozotocin-Induced Diabetes as a Model of Diabetic Retinopathy in Brown Norway Rats
Longitudinal Validation Study: Streptozotocin-Induced Diabetes as a Model of Diabetic Retinopathy in Brown Norway Rats Robin Dean, Robert Sukhu, Leslie Nemeth, Qin Zhang, Isaac Hakim, Ali Ebramhimnejad,
More informationUse of the Free Electron Laser for the Noninvasive Determination of Retinal Oxyhemoglobin Saturation by Near Infrared Reflectance Spectrophotometry
Use of the Free Electron Laser for the Noninvasive Determination of Retinal Oxyhemoglobin Saturation by Near Infrared Reflectance Spectrophotometry Ref: Eye, M.C. Escher, 1946 Ref: Eye, M.C. Escher, 1946
More informationGuidelines for the Management of Diabetic Retinopathy for the Internist
Visual Disorder Guidelines for the Management of Diabetic Retinopathy for the Internist JMAJ 45(1): 1 7, 2002 Sadao HORI Professor, Department of Ophthalmology, Tokyo Women s Medical University Abstract:
More informationRetinal vascular patterns
Retinal vascular patterns VII. Acellular change Toichiro Kuwabara and David G. Cogan The trypsin digestion technique has revealed a preferential loss of endothelial cells (in conditions other than diabetes)
More informationGConsidering the extensive use of experimental
Observation of retinopathy in metahypophyseal diabetic Chinese hamsters T H. R. Hausler, T. M. Sibay, and B. Stachowska Arteriolar and capillary aneurysms were observed in 12 metahypophyseal diabetic gray
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.
More informationDiabetes Care 24: , 2001
Pathophysiology/Complications O R I G I N A L A R T I C L E Prevalence and Significance of Retinopathy in Subjects With Type 1 Diabetes of Less Than 5 Years Duration Screened for the Diabetes Control and
More informationDiabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012
Diabetic Retinopathy Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012 Outline Statistics Anatomy Categories Assessment Management Risk factors What do you need to do? Objectives Summarize the
More informationHyperglycemia induces metabolic disorders that
Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy Renu A. Kowluru, 1 Jie Tang, 2 and
More informationLecture 19 Summary Gestational Diabetes and Complications of Diabetes. Gestational diabetes;
Lecture 19 Summary Gestational Diabetes and Complications of Diabetes Gestational diabetes; - Type of diabetes that only develops during pregnancy Usually diagnosed in late pregnancy Causes high blood
More informationPrevalence of diabetic retinopathy in diabetics of rural population belonging to Ramanagara and Chikkaballapura districts of Karnataka
International Journal of Scientific and Research Publications, Volume 5, Issue 3, March 215 1 ISSN 225-3153 Prevalence of diabetic retinopathy in diabetics of rural population belonging to Ramanagara and
More informationA theory for explaining the etiology of
Lens assays on diabetic and galactosemic rats receiving diets that modify cataract development John W. Patterson, Margaretta E. Patterson, V. Everett Kinsey, and D. V. N. Reddy Cataract formation is delayed
More informationThe Role of Aidose Reductase in Diabetic Retinopathy: Prevention and Intervention Studies
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Papers in Veterinary and Biomedical Science Veterinary and Biomedical Sciences, Department of January 1995 The Role of Aidose
More informationThe Patency of the Retinal Vasculature to Erythrocytes in Retinal Vascular Disease
Investigative Ophthalmology & Visual Science, Vol. 31, No. 3, March 1990 Copyright Association for Research in Vision and Ophthalmology The Patency of the Retinal Vasculature to Erythrocytes in Retinal
More informationretinal microaneurysm development in diabetic patients
362 British tournal of Ophthalmology 1995; 79: 362-367 ORIGINAL ARTICLES - Laboratory science Department of Ophthalmology, The Queen's University of Belfast, The Royal Victoria Hospital, Institute of Clinical
More informationmeasure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control
More informationImmunohistochemical Localization For Aldose Reductase in Diabetic Lenses
Immunohistochemical Localization For Aldose Reductase in Diabetic Lenses Yoshio Akagi, Pefer F. Kador, ond Jin H. Kinoshira Sugar cataract formation has been demonstrated to result from lenticular sorbitol
More informationEXUDATIVE DIABETIC RETINOPATHY* SPONTANEOUS CHANGES AND EFFECTS OF A CORN OIL DIET
Brit. J. Ophthal. (1963) 47, 666. EXUDATIVE DIABETIC RETINOPATHY* SPONTANEOUS CHANGES AND EFFECTS OF A CORN OIL DIET BY R. C. KING, J. H. DOBREE, D'A. KOK, W. S. FOULDS, AND W. G. DANGERFIELD St. Bartholomew's
More informationLong-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation
Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation Murat Dogru, Makoto Nakamura, Masanori Inoue and Misao Yamamoto Department of Ophthalmology, Kobe
More informationDeficiencies of Vitamins E and A in the Rat: Lipofuscin Accumulation in the Choroid
Deficiencies of Vitamins E and A in the Rat: Lipofuscin Accumulation in the Choroid Roland K. Herrmann,* W. Gerald Robison, Jr.,* and John G. Dieri-)- The effects of vitamin E and A deficiencies on the
More informationPolyol Formation and NADPH-Dependent Reductases in Dog Retinal Capillary Pericytes and Endothelial Cells
Polyol Formation and NADPH-Dependent Reductases in Dog Retinal Capillary Pericytes and Endothelial Cells Sanai Sato, E. Filippo Secchi, Martin J. Lizak, Shigeru Fukase, Nobuo Ohta, Masatoshi Murata, Jen-Yue
More informationCase Report: Indocyanine Green Dye Leakage from Retinal Artery in Branch Retinal Vein Occlusion
Case Report: Indocyanine Green Dye Leakage from Retinal Artery in Branch Retinal Vein Occlusion Hiroki Fujita, Kyoko Ohno-Matsui, Soh Futagami and Takashi Tokoro Department of Visual Science, Tokyo Medical
More informationEffects of Insulin Insufficiency and High Glucose on Cell Survival of Dog Retinal Capillary Pericytes
Int J Diabetes & Metabolism (2000) 8:93-100 93 Effects of Insulin Insufficiency and High Glucose on Cell Survival of Dog Retinal Capillary Pericytes Masatoshi Murata, Shinichi Sakurai, Peter F. Kador and
More informationDiabetic and the Eye: An Introduction
Diabetic and the Eye: An Introduction Lawrence Iu FRCSEd (Ophth), FCOphthHK, FHKAM (Ophthalmology) Department of Ophthalmology, Grantham Hospital & Queen Mary Hospital Background Diabetes mellitus (DM)
More informationCorneal Re-epithelialization in Galactosemic Rats
Corneal Re-epithelialization in Galactosemic Rats Manuel B. Doriles, Perer F. Kador, Henry N. Fukui, Tian-Sheng Hu, and Jin H. Kinoshiro Abnormalities in corneal epithelial healing in diabetic patients
More informationClinically Significant Macular Edema (CSME)
Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2
More informationPathology of endocrine pancreas. By: Shifaa Alqa qa
Pathology of endocrine pancreas By: Shifaa Alqa qa major cell types: Beta ----- insulin Alpha ----- glucagon Delta ----- somatostatin PP (pancreatic polypeptide) cells ------ VIP DIABETES MELLITUS Normal
More informationINTRODUCTION AND SYMPTOMS
CHAPTER 1 INTRODUCTION AND SYMPTOMS Introduction of Diabetic Retinopathy Diabetic retinopathy (DR) is a potentially blinding complication of diabetes. It is defined as presence of one or more definite
More informationDIABETIC RETINOPATHY
DIABETIC RETINOPATHY C. L. B. Canny, MD FRCSC Diabetic retinopathy is the most serious eye manifestation of diabetes and is responsible for most of the blindness caused by diabetes. Diabetic retinopathy
More informationReports. Ocular vascular and epithelial barriers to
Reports Ocular vascular and epithelial barriers to microperoxidase. RICHARD S. SMITH AND LINDA A. RUDT. Microperoxida.se (MP) is an ultrastructural tracer of small molecular weight (1,900) derived from
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationNew Developments in the treatment of Diabetic Retinopathy
New Developments in the treatment of Diabetic Retinopathy B. Jeroen Klevering University Medical Centre Nijmegen - The Netherlands Topics Management of diabetic retinopathy Interventions a. primary (prevention)
More informationDiabetic Retinopathy A Presentation for the Public
Diabetic Retinopathy A Presentation for the Public Ray M. Balyeat, MD The Eye Institute Tulsa, Oklahoma The Healthy Eye Light rays enter the eye through the cornea, pupil and lens. These light rays are
More informationDisease-Specific Fluorescein Angiography
Ruth E. Picchiottino, CRA Disease-Specific Fluorescein Angiography 15 Disease-Specific Fluorescein Angiography Recommendations for tailoring retinal fluorescein angiography to diabetic retinopathy, macular
More informationObese Type 2 Diabetic Model. Rat Model with Early Onset of Diabetic Complications. SDT fatty rats. SDT fatty rats
Obese Type 2 Diabetic Model rats Rat Model with Early Onset of Diabetic Complications rats Background and Origin In 24, Dr. Masuyama and Dr. Shinohara (Research Laboratories of Torii Pharmaceutical Co.,
More informationand anions in the Hofmeister or lyotropic series that favor amino acids (2). Osmotically active organic solutes with these
Sorbitol, Osmoregulation, and the Complications of Diabetes Perspectives Maurice B. Burg and Peter F. Kador National Heart, Lung and Blood Institute, and National Eye Institute, National Institutes ofhealth,
More informationDiabetologia 9 Springer-Verlag 1983
Diabetologia (1983) 24:293 299 Diabetologia 9 Springer-Verlag 1983 Electron Microscopy of Renal and Ocular Changes in Virus-Induced Diabetes Mellitus in Mice M. Rodrigues t, C. Currier 1 and J. Yoon 2
More informationPROGRESSION OF DIABETIC RETINOPATHY FOLLOWING CATARACT SURGERY
PROGRESSION OF DIABETIC RETINOPATHY FOLLOWING CATARACT SURGERY Yayan Heryanto, Iwan Sovani, Arief Kartasasmita, Erwin Iskandar, Djonggi Panggabean. Dept. of Ophthalmology Medical Faculty Unpad, Cicendo
More informationUse of Scanning Laser Ophthalmoscope Microperimetry in Clinically Significant Macular Edema in Type 2 Diabetes Mellitus
Use of Scanning Laser Ophthalmoscope Microperimetry in Clinically Significant Macular Edema in Type 2 Diabetes Mellitus Fumihiko Mori, Satoshi Ishiko, Norihiko Kitaya, Taiichi Hikichi, Eiichi Sato, Akira
More informationThe retinal renin-angiotensin system: implications for therapy in diabetic retinopathy
(2002) 16, S42 S46 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh : implications for therapy in diabetic retinopathy AK Sjølie 1 and N Chaturvedi 2 1 Department
More informationDiabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?
Retinopathy Diabetes has a negative effect on eyes in many ways, increasing the risk of cataracts for example, but the most common and serious ocular complication of diabetes is retinopathy. Diabetic retinopathy
More informationStudy of correlation of severity of diabetic retinopathy with levels of haemogloelbin A1c in patients with type II Diabetes Mellitus
Original article: Study of correlation of severity of diabetic retinopathy with levels of haemogloelbin A1c in patients with type II Diabetes Mellitus 1Dr Apoorva*, 2 Dr Sabhia Jan 1Senior Resident, 2
More informationA Patient s Guide to Diabetic Retinopathy
Diabetic Retinopathy A Patient s Guide to Diabetic Retinopathy 840 Walnut Street, Philadelphia PA 19107 www.willseye.org Diabetic Retinopathy 1. Definition Diabetic retinopathy is a complication of diabetes
More informationDIABETES MELLITUS: COMPLICATION. Benyamin Makes Dept. of Anatomic Pathology FMUI - Jakarta
DIABETES MELLITUS: COMPLICATION Benyamin Makes Dept. of Anatomic Pathology FMUI - Jakarta COMPLICATION OF DIABETES Susceptibility to infections including tuberculosis, pneumonia, pyelonephritis, and mucocutaneous
More informationLeo Semes, OD, FAAO UAB Optometry
Leo Semes, OD, FAAO UAB Optometry Safe; inert Has long track record - over 45 years Mixes with plasma and highlights blood vessel compromise Using specific exciting (490 nm)and absorption (510 nm) filters
More informationchorioretinal atrophy
British Journal of Ophthalmology, 1987, 71, 757-761 Retinal microangiopathy in pigmented paravenous chorioretinal atrophy SURESH R LIMAYE AND MUNEERA A MAHMOOD From the Ophthalmology Service, DC General
More informationDiabetologia 9 Springer-Verlag 1990
Diabetologia (1990) 33:515-521 Diabetologia 9 Springer-Verlag 1990 Originals Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat A. Das, R. N. Frank
More informationAbnormalities of the retinal veins are. loops and reduplications in diabetic retinopathy. Prevalence, distribution, and pattern of development
Venous loops and reduplications in diabetic retinopathy Prevalence, distribution, and pattern of development Toke Bek Department of Ophthalmology, Århus University Hospital, DK-8000 Århus C, Denmark ABSTRACT.
More informationΟ ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη
Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη Κωνσταντίνος Τζιόμαλος Επίκουρος Καθηγητής Παθολογίας Α Προπαιδευτική Παθολογική Κλινική, Νοσοκομείο
More informationDiabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion
European Journal of Ophthalmology / Vol. 13 no. 7, 2003 / pp. 648-652 Diabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion J. SWART 1,2, J.W. REICHERT-THOEN 1, M.S.
More informationGlycemic Control and Diabetic Complications
Glycemic Control and Diabetic Complications SUZANNE STROWIG, RN, MSN PHIUP RASKIN, MD The relationship between glycemic control and diabetic complications remains unclear. Epidemiological studies reveal
More informationZEISS AngioPlex OCT Angiography. Clinical Case Reports
Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy
More informationDiabetic ocular complications are a leading PROCEEDINGS MOLECULAR BIOLOGY AND NATURAL HISTORY OF DIABETIC RETINOPATHY * Lloyd P.
MOLECULAR BIOLOGY AND NATURAL HISTORY OF DIABETIC RETINOPATHY * Lloyd P. Aiello, MD, PhD ABSTRACT Diabetic retinopathy is the most common diabetic microvascular complication, affecting approximately 50%
More informationInduction of endothelial cell proliferation in rat retinal venules by chemical and indirect physical trauma
Induction of endothelial cell proliferation in rat retinal venules by chemical and indirect physical trauma Clark W. Deem, Sidney Futterman, and Robert E. Kalina The capacity of retinal vessels to incorporate
More informationOptic Nerve Disorders: Structure and Function and Causes
Optic Nerve Disorders: Structure and Function and Causes Using Visual Fields, OCT and B-scan Ultrasound to Diagnose and Follow Optic Nerve Visual Losses Ohio Ophthalmological Society and Ophthalmic Tech
More informationGrand Rounds: Interesting and Exemplary Cases From Guanajuato and Djibouti
Learning Community: January 25, 2015 Grand Rounds: Interesting and Exemplary Cases From Guanajuato and Djibouti JORGE CUADROS, OD, PHD EyePACS In Guanajuato Program started in 2007 Cameras go from clinic
More informationPlasminogen activators (PAs) are serine proteases produced
Plasminogen Activator Inhibitor (PAI)-1 Overexpression in Retinal Microvessels of PAI-1 Transgenic Mice Maria B. Grant, 1 Polyxenie E. Spoerri, 1 Denifield W. Player, 2 David M. Bush, 1,3 E. Ann Ellis,
More informationDiabetic retinopathy (DR) and its associated
EPIDEMIOLOGY AND IMPACT OF DIABETIC RETINOPATHY Thomas A. Ciulla, MD * ABSTRACT Diabetes mellitus has become a worldwide concern, affecting an estimated 171 million adults. Patients with diabetes commonly
More informationDiabetes Eye Q Quiz. 1) Diabetes is the leading cause of new blindness among adults in the US under the age of 74.
Diabetes Eye Q Quiz From 1997 to 2011, the number of adults with diagnosed diabetes who reported visual impairment, that is, trouble seeing even with their glasses or contact lenses, increased from 2.7
More informationEyes on Diabetics: How to Avoid Blindness in Diabetic Patient
Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient Rova Virgana FK Unpad Pusat Mata Nasional RS Mata Cicendo Bandung Eye Center (Hospital and Clinic) PIT IDI Jabar 2018 Keys Facts from WHO
More informationSpeaker Disclosure Statement. " Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose.
Speaker Disclosure Statement Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose. Diabetes Morbidity Diabetes doubles the risk of stroke. Diabetes quadruples the risk of
More informationDiabetes Mellitus. Disorder of metabolism (Carb, Prot & Fat) Due to Absolute/relative deficiency of insulin. Characterized by hyperglycemia.
Diabetes Mellitus Disorder of metabolism (Carb, Prot & Fat) Due to Absolute/relative deficiency of insulin. Characterized by hyperglycemia. Clinically : Polyuria, Polydypsia, Polyphagia. Diabetes Classification
More informationBarry S. Winkler, Matthew J. Arnold, Melissa A. Brassell, and Denise R. Sliter
Glucose Dependence of Glycolysis, Hexose Monophosphate Shunt Activity, Energy Status, and the Polyol Pathway in Retinas Isolated From Normal (Nondiabetic) Rats Barry S. Winkler, Matthew J. Arnold, Melissa
More informationRetinal vessel dilatation and elongation precedes diabetic macular oedema
274 Department of Ophthalmology, University of Iceland, Landakotsspítali, Reykjavík, Iceland K Kristinsson M S Gottfredsdóttir E Stefánsson Correspondence to: Einar Stefánsson, MD, PhD, University of Iceland,
More informationInternational Journal of ChemTech Research CODEN (USA): IJCRGG ISSN: Vol.8, No.6, pp , 2015
International Journal of ChemTech Research CODEN (USA): IJCRGG ISSN: 0974-4290 Vol.8, No.6, pp 607-611, 2015 Retinal Digest Procedures for Examining Pericyte and Endothelial On Retinal Vasculature Using
More informationDr/ Marwa Abdellah EOS /16/2018. Dr/ Marwa Abdellah EOS When do you ask Fluorescein angiography for optic disc diseases???
When do you ask Fluorescein angiography for optic disc diseases??? 1 NORMAL OPTIC DISC The normal optic disc on fluorescein angiography is fluorescent due to filling of vessels arising from the posterior
More informationElastic Skeleton of Intracranial Cerebral Aneurysms in Rats
1722 Elastic Skeleton of Intracranial Cerebral Aneurysms in Rats Naohiro Yamazoe, MD, Nobuo Hashimoto, MD, Haruhiko Kikuchi, MD, and Fumitada Hazama, MD In an attempt to clarify the developmental mechanism
More informationDIABETES AND YOUR EYES. Presented by Dr. Andrea Hagler
DIABETES AND YOUR EYES Presented by Dr. Andrea Hagler Tahlequah, OK Forest Grove, OR Brief Review of Diabetes The body s endocrine system is responsible for regulating growth, reproduction, and tissue
More informationDiabetes & Your Eyes
Diabetes & Your Eyes Diabetes is a disease that occurs when the pancreas does not secrete enough insulin or the body is unable to process it properly. Insulin is the hormone that regulates the level of
More informationDiabetic Retinopathy Screening Program in the Cree Region of James Bay of Quebec
RUIS McGILL VIRTUAL HEALTH AND SOCIAL SERVICES CENTRE (CvSSS) SIMPLIFYING TELEHEALTH! Diabetic Retinopathy Screening Program in the Cree Region of James Bay of Quebec Nurse and Imager Training Prepared
More informationQUANTITATIVE HISTOCHEMISTRY OF THE NEPHRON. V.
QUANTITATIVE HISTOCHEMISTRY OF THE NEPHRON. V. ALKALINE PHOSPHATASE AND LACTIC DEHYDROGENASE ACTIVITIES IN LUPUS NEPHRITIS * By VICTOR E. POLLAK,t SJOERD L. BONTING, ROBERT C. MUEHRCKE AND ROBERT M. KARK
More informationPearls, Pitfalls and Advances in Neuro-Ophthalmology
Pearls, Pitfalls and Advances in Neuro-Ophthalmology Nancy J. Newman, MD Emory University Atlanta, GA Consultant for Gensight Biologics, Santhera Data Safety Monitoring Board for Quark AION Study Medical-legal
More informationHyperglycemia is the initiating event in the development
Effect of Reinstitution of Good Glycemic Control on Retinal Oxidative Stress and Nitrative Stress in Diabetic Rats Renu A. Kowluru Clinical and experimental studies have shown that reinstitution of good
More informationOCT Assessment of the Vitreoretinal Relationship in CSME
December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction
More informationEyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy. George Bresnick MD MPA Jorge Cuadros OD PhD
EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy George Bresnick MD MPA Jorge Cuadros OD PhD Anatomy of the eye: 3 Normal Retina Retinal Arcades Macula Optic
More informationNovel imaging techniques for diabetic macular edema
Documenta Ophthalmologica 97: 341 347, 1999. T.J. Wolfensberger (ed.), Conference Proceedings of the 2 nd International Symposium on Macular Edema, 137 143. 2000 Kluwer Academic Publishers. Printed in
More informationCLINICAL SCIENCES. Computer Classification of Nonproliferative Diabetic Retinopathy. is characterized by structural
CLINICAL SCIENCES Computer Classification of Nonproliferative Diabetic Retinopathy Samuel C. Lee, PhD; Elisa T. Lee, PhD; Yiming Wang, MS; Ronald Klein, MD; Ronald M. Kingsley, MD; Ann Warn, MD Objective:
More informationOptical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
More informationMeasurement of Subfoveal Choroidal Thickness Using Spectral Domain Optical Coherence Tomography
c l i n i c a l s c i e n c e Measurement of Subfoveal Choroidal Thickness Using Spectral Domain Optical Coherence Tomography Emily A. McCourt, MD; Brian C. Cadena, PhD; Cullen J. Barnett, CRA; Antonio
More informationStudies on intravitreal blood vessels. II. Effectiveness of xenon arc and argon laser photocoagulation in blood vessel closure
Studies on intravitreal blood vessels. II. Effectiveness of xenon arc and argon laser photocoagulation in blood vessel closure Gholam A. Peyman, Jeff E. Koziol, Donald R. Sanders, and Joseph K. Vlchek
More informationDiabetic retinopathy (DR) was first PROCEEDINGS DIABETIC RETINOPATHY * Ronald Klein, MD, MPH ABSTRACT
DIABETIC RETINOPATHY * Ronald Klein, MD, MPH ABSTRACT Diabetic retinopathy (DR) is characterized by the development of retinal microaneurysms, hemorrhages, deposits of leaked lipoproteins (hard exudates),
More informationUpdate on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals
Disease Models & Mechanisms 5, 444-456 (2012) doi:10.1242/dmm.009597 Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals Remya Robinson 1, *, Veluchamy
More informationDiabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people
Diabetic Retinopathy What is diabetic eye disease? Diabetic eye disease refers to a group of eye problems that people with diabetes may face as a complication of diabetes. All can cause severe vision loss
More informationOutline. Preventing & Treating Diabetes Related Blindness. Eye Care Center Doctors. Justin Kanoff, MD. Eye Care Center of Northern Colorado
Outline Preventing & Treating Diabetes Related Blindness Justin Kanoff, MD Eye Care Center of Northern Colorado 303 974 4302 Introduction to Eye Care Center of Northern Colorado How the eye works Eye problems
More informationOCT Angiography in Primary Eye Care
OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central
More informationIn its initial report, the Early Treatment Diabetic Retinopathy. A Severity Scale for Diabetic Macular Edema Developed from ETDRS Data
A Severity Scale for Diabetic Macular Edema Developed from ETDRS Data Ronald E. Gangnon, 1,2 Matthew D. Davis, 3 Larry D. Hubbard, 3 Lloyd M. Aiello, 4 Emily Y. Chew, 5 Frederick L. Ferris III, 5 Marian
More information2/15/2018 NEW FRONTIERS IN THE DIAGNOSIS & TREATMENT OF DIABETIC RETINOPATHY FINANCIAL DISCLOSURES OBJECTIVES. Prevalence of Diabetes
NEW FRONTIERS IN THE DIAGNOSIS & TREATMENT OF DIABETIC RETINOPATHY Craig Thomas, O.D. 3900 West Wheatland Road Dallas, Texas 75237 972-780-7199 thpckc@yahoo.com FINANCIAL DISCLOSURES I am a paid consultant
More informationFactors Associated with Visual Outcome after Photocoagulation for Diabetic Retinopathy
Investigative Ophthalmology & Visual Science, Vol. 30, No. 1, January 1989 Copyright Association for Research in Vision and Ophthalmology Factors Associated with Visual Outcome after Photocoagulation for
More informationDiabetic Retinopatathy
Diabetic Retinopatathy Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Arctic DX Macula Risk Advanced
More informationChorioretinal vascular occlusions with latex microspheres (a long-term study). Part II. Howard Golclor and Andrew J. Gay
Chorioretinal vascular occlusions with latex microspheres (a long-term study). Part II Howard Golclor and Andrew J. Gay The results of a long-term study (3 to 9 months) of chorioretinal vascular occlusions
More information